
Novo Nordisk is cutting the out-of-pocket prices of its popular weight-loss drug Wegovy and diabetes drug Ozempic for some consumers.
Current customers who pay for the drugs out of pocket — without the help of health insurance — will now be charged $349 per month, down from $499, the Danish drugmaker said Monday.
Novo Nordisk also announced that it will charge $199 per month for new patients who pay for the drugs out of pocket, with the offer covering two months of the treatments. After that, the cost of the drugs will rise to $349 per month. The introductory $199 offer will be available through March 31, 2026, it said.
The new pricing for people who pay out of pocket for the two popular drugs comes amid a push from the Trump administration to lower their prices. In a deal announced earlier this month, the administration said people who rely on Medicare, Medicaid and the planned "TrumpRx" pharmaceutical website will get lower pricing for Novo Nordisk's GLP-1 drugs, as well as Eli Lilly's Zepbound.
At the time, administration officials said the drugs would cost an average of $245 to $350, a more accessible price point given they can retail for more than $1,000 per month.
Dave Moore, executive vice president of U.S. operations of Novo Nordisk, told CBS News in a statement that the company's new offer is intended to expand access to medicines for patients living with chronic diseases.
"Novo Nordisk is making it easier and more affordable for patients to access real FDA-approved treatments," he said.
Customers can get prescriptions at the new prices at wegovy.com or ozempic.com, at NovoCare Pharmacy or through other select providers such as Costco.
When the employed are pushed into homelessness
President Trump's pardon of crypto billionaire sparks concerns over his use of pardons
LATEST POSTS
- 1
Building an Individual Brand: Illustrations from Powerhouses - 2
The Conclusive Manual for Spending plan Travel: Opening Undertakings on a Tight budget - 3
Astronomers now say the moon is eating up molecules from Earth’s atmosphere - 4
How a Snake That Eats Cobras Redefined the Meaning of ‘King’ - 5
Aluminum salts emerge as likely target as health officials scrutinize childhood vaccines
A milestone for Artemis II: Astronauts enter the 'lunar sphere of influence'
Are Saturn's rings made of a lost, shattered moon? New evidence arises for the case
Who is Artemis? Meet the Greek goddess who inspired NASA's return to the moon
AI’s errors may be impossible to eliminate – what that means for its use in health care
The 15 Most Powerful Forerunners in Business
See a half-lit moon shine among the stars of Aquarius on Nov. 27
Worldwide Objections Ideal For A Golf Outing
Jillian Michaels put me at the center of a body positivity debate. She's not entirely wrong about obesity.
Director of Swiss hospital describes the rush to treat the injured from Alpine resort bar fire













